Luz Candenas

Dr. Luz Candenas


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2004 in Life Sciences
Verified
Journal Article
Closed access
JPJocelyn N Pennefather
Jocelyn N Pennefather
ALAlessandro Lecci
Alessandro Lecci
LCLuz Candenas
Luz Candenas
EPEva Patak
Eva Patak
FPFrancisco Pinto
Francisco Pinto
CMCarlo Alberto Maggi
Carlo Alberto Maggi

1 September 1995 in Chemical Reviews
Verified
Journal Article
Closed access
EAEleuterio. Alvarez
Eleuterio. Alvarez
LCLuz Candenas
Luz Candenas
RPRicardo. Perez
Ricardo. Perez
JRJose Luis. Ravelo
Jose Luis. Ravelo
JMJulio. Delgado Martin
Julio. Delgado Martin

Verified
Journal Article
Open access
PDF file
LCLuz Candenas
Luz Candenas
RCRosanna Chianese
Rosanna Chianese
Infertility has become a global health issue, with approximately 50% of infertility cases generated by disorders in male reproduction. Spermatozoa are conveyed towards female genital tracts in a safe surrounding provided by the seminal plasma. Interestingly, this dynamically changing medium is a rich source of proteins, essential not only for sperm transport, but also for its protection and maturation. Most of the seminal proteins are acquired by spermatozoa in transit through exosomes (epididymosomes and prostasomes). The high number of seminal proteins, the increasing knowledge of their origins and biological functions and their differential expression in the case of azoospermia, asthenozoospermia, oligozoospermia and teratozoospermia or other conditions of male infertility have allowed the identification of a wide variety of biomarker candidates and their involvement in biological pathways, thus to strongly suggest that the proteomic landscape of seminal plasma may be a potential indicator of sperm dysfunction. This review summarizes the current knowledge in seminal plasma proteomics and its potentiality as a diagnostic tool in different degrees of male infertility.

1 May 2012 in Fertility and Sterility
Verified
Journal Article
Closed access
ARAntonio Cejudo Roman
Antonio Cejudo Roman
FPFrancisco Pinto
Francisco Pinto
IDIdaira Dorta
Idaira Dorta
TATeresa Almeida
Teresa Almeida
MHMariano Hernández
Mariano Hernández
LCLuz Candenas
Luz Candenas

1 June 2004 in European Journal of Pharmacology
Verified
Journal Article
Closed access
FPFrancisco Pinto
Francisco Pinto
TATeresa Almeida
Teresa Almeida
MHMariano Hernandez
Mariano Hernandez
PDPhilippe Devillier
Philippe Devillier
CACharles Advenier
Charles Advenier
LCLuz Candenas
Luz Candenas

9 June 2011 in International Journal of Andrology
Verified
Journal Article
Open access
PDF file
FPFrancisco Pinto
Francisco Pinto
ACA. Cejudo‐Román
A. Cejudo‐Román
CRC. G. Ravina
C. G. Ravina
MFManuel Fernández-Sánchez
Manuel Fernández-Sánchez
DMD. Martín‐Lozano
D. Martín‐Lozano
LCLuz Candenas
Luz Candenas
Summary: Kisspeptin, the product of the KISS1 gene, plays an essential role in the regulation of spermatogenesis acting primarily at the hypothalamic level of the gonadotropic axis. However, the presence of kisspeptin and its canonical receptor, KISS1R, in spermatozoa has not been explored nor the direct effects of kisspeptin on sperm function have been studied so far. In the present study, we analysed the expression of kisspeptin and its receptor in sperm cells by western blot and immunocytochemistry assays and evaluated the effects of exposure to kisspeptin on sperm intracellular Ca2+ concentration, [Ca2+]i, sperm motility, sperm hyperactivation and the acrosome reaction. Changes in [Ca2+]i were monitored using Fura‐2, sperm kinematic parameters were measured using computer‐assisted sperm analysis (CASA), and the acrosome reaction was measured using fluorescein isothiocyanate‐coupled Pisum sativum agglutinin lectin (FITC–PSA method). We found that kisspeptin and its receptor are present in sperm cells, where both are mainly localized in the sperm head, around the neck and in the flagellum midpiece. Exposure to kisspeptin caused a slow, progressive increase in [Ca2+]i, which reached a plateau about 3–6 min after kisspeptin exposure. In addition, kisspeptin modulated sperm progressive motility causing a biphasic (stimulatory and inhibitory) response and also induced transient sperm hyperactivation. The effects of kisspeptin on sperm motility and hyperactivation were inhibited by the antagonist of KISS1R, peptide 234. Kisspeptin did not induce the acrosome reaction in human spermatozoa. These data show for the first time that kisspeptin and its receptor are present in human spermatozoa and modulate key parameters of sperm function. This may represent an additional mechanism for their crucial function in the control of male fertility.